The 14 references in paper S. Ovcharenko I., С. Овчаренко И. (2014) “Хроническая обструктивная болезнь легких: реальная ситуация в России и пути ее преодоления // Chronic obstructive pulmonary disease: actual situation in Russia and ways to solve the problem” / spz:neicon:pulmonology:y:2011:i:6:p:69-72

1
Чучалин А.Г.(ред.). Хроническая обструктивная болезнь легких. Федеральная программа. 2-е изд. М.; 2004.
(check this in PDF content)
2
Buist A.S., McBurnie M.A., Vollmer W.M. et al.International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 2007; 370: 741–750.
(check this in PDF content)
3
Murray C.J., Lopez A.D. Alternative projections of mortalilty and disbility by cause 1990–2020: Global Burden of Disease Study. Lancet 1997; 349 (9064): 1498–1504.
(check this in PDF content)
4
Rabin R., de Charro F.EQ-5D: a measure of health status from the EuroQol Group. Ann. Med. 2001; 33 (5): 337–343.
(check this in PDF content)
5
Global Initiative for Chronic Obstructive Lung Disease (GOLD). U.S. Department of Health and Human Services, National Institute of Health, National Heart, Lung, and Blood Institute; 2006 (www.goldcopd.com).
(check this in PDF content)
6
Han M.R., Postma D., Mannino D.M. et al.Gender and chronic obstructive pulmonary disease: why it matters. Am. J. Respir. Crit. Care Med. 2007; 176: 1179–1184.
(check this in PDF content)
7
Sorheim I.C., Johannessen A., Gulsvik A. et al. Gender differencies in COPD: are women more susceptible to smoking effects than men? Thorax 2010; 65: 480–485.
(check this in PDF content)
8
Decramer M., Celli B., Kesten S. et al.Effect of Tiotropium on outcomes in patients with moderate COPD (UPLIFT): a prespecifies subgroup analysis of a randomised controlled trial. Lancet 2009; 374: 1171–1178.
(check this in PDF content)
9
Decramer M., Cooper C.B. Treatment of COPD: the sooner the better? Thorax 2010; 65: 837–841.
(check this in PDF content)
10
Donaldson G.C., Seemungal T.A.R., Bhowmik A., Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in COPD. Thorax 2002; 57: 847–852.
(check this in PDF content)
11
Spencer S., Jones P.W.Time course of ercovery of health status following an infective exacerbation of chronic bronchitis. Thorax 2003; 58: 589–593.
(check this in PDF content)
12
Soler-Cataluna J.J., Martinez-Garcia M.A., Roman S.P. et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925–931.
(check this in PDF content)
13
Rabe K.F., Hurd S., Anzueto A. et al.Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007; 176 (6): 532–555.
(check this in PDF content)
14
Toy E.L., Gallagher K.F., Stanley E.L. et al.The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD 2010; 7: 214–228. Информация об авторе
(check this in PDF content)